Up to today, acetylcholinesterase (AChE) is an attractive target for the treatment of Alzheimer’s disease, and acetylcholinesterase inhibitors represent the major approved drugs to treat this neurodegenerative disease (37). The gene discussed is ACHE; the disease is neurodegenerative disease.